We added the following clinical trials to Metastatic Trial Search for July/August 2025. To see all clinical trials, please visit Metastatic Trial Search.

ER/PR Positive Trials

• Zelenectide Pevedotin Targeted Therapy for Advanced HR+, HER2- or Triple Negative Breast Cancer That Expresses NECTIN4
• ENV-501 Antibody Drug Conjugate for Advanced HR+, HER2-, HER3+ Breast Cancer

HER2 Low Trials

• Sequence of Two ADCs for Advanced HER2 Low Breast Cancer

Triple Negative Trials

• Azirkitug Immunotherapy Alone or With Immunotherapy or Targeted Therapy for Advanced Triple Negative Breast Cancer

Other Stage IV Trials

• EIK1004 Targeted Therapy for Advanced Breast Cancer with HRR Mutations
• MT-4561 Targeted Therapy for Advanced Breast Cancer

Last Modified on July 1, 2025